Company: DHR
Filing Date: 2025-10-21
Form Type: 10-Q
Source: 0000313616-25-000182
Chunk: 86

Company: DANAHER CORP /DE/
Filing Date: 2025-10-21
Form: 10-Q
Item: Item 8
Chunk 86
---
2,463 $— $6,053 Less:Depreciation(38)(47)(101)(3)(189)Amortization of intangible assets(231)(154)(48)— (433)Impairments(b)(86)— (15)— (101)Other segment expenses(c)(1,091)(1,369)(1,634)(82)(4,176)Operating profit$352 $222 $665 $(85)$1,154 For the Three-Month Period Ended September 27, 2024:Sales$1,653 $1,782 $2,363 $— $5,798 Less:Depreciation(36)(44)(95)(2)(177)Amortization of intangible assets(218)(147)(49)— (414)Impairments(b)— (222)— — (222)Other segment expenses(c)(1,009)(1,334)(1,604)(80)(4,027)Operating profit (loss)$390 $35 $615 $(82)$958 

11

BiotechnologyLife SciencesDiagnosticsOther(a)TotalFor the Nine-Month Period Ended September 26, 2025:Sales$5,260 $5,249 $7,221 $— $17,730 Less:Depreciation(110)(137)(301)(7)(555)Amortization of intangible assets(672)(453)(144)— (1,269)Impairments(b)(101)(432)(15)— (548)Other segment expenses(c)(3,053)(4,043)(4,824)(250)(12,170)Operating profit$1,324 $184 $1,937 $(257)$3,188 For the Nine-Month Period Ended September 27, 2024:Sales$4,890 $5,297 $7,150 $— $17,337 Less:Depreciation(113)(123)(292)(6)(534)Amortization of intangible assets(650)(428)(145)— (1,223)Impairments(b)— (222)— — (222)Other segment expenses(c)(2,950)(4,021)(4,712)(237)(11,920)Operating profit (loss)$1,177 $503 $2,001 $(243)$